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Introduction
Monovision represents a well-established method of presbyopic correction whereby the dominant eye is commonly corrected for far vision and the nondominant eye for near vision. Monovision laser refractive surgery for the simultaneous correction of ametropia and presbyopia was first described in 1999 as a photorefractive keratectomy (PRK) procedure (1) and has since evolved to become a valuable part of the armamentarium of refractive surgery (2) . A plethora of more recent studies has particularly approved laser-assisted in situ keratomileusis (LASIK) monovision as a viable option compared with LASIK and PRK, which may be beneficial with respect to quality of night vision (22) (23) (24) (25) . However, the less pronounced introduction of spherical aberration might in turn compromise the depth of field and thereby hamper the success of SMILE-induced monovision in presbyopic patients.
The rationale of the present study was to evaluate of the functional outcomes of SMILE monovision for the simultaneous correction of myopia or myopic astigmatism and presbyopia.
Methods
For the purpose of this interventional case series, the database of the SMILE Eyes Clinic Linz, Austria, comprising 1,058 SMILE procedures of 534 patients, was screened for subjects who had undergone bilateral SMILE for the treatment of myopia or myopic astigmatism with planned monovision. The inclusion criteria were a minimum age of 45 years at the time of surgery, a monocular corrected distance visual acuity (CDVA) of 20/25 or better in both eyes, as well as a binocular distance-corrected near visual acuity (DCNVA) of Jaeger 1 (J1 or 20/25 Snellen equivalent) or worse. Moreover, only patients with a minimum follow-up of 2 months were included.
Institutional review board approval was obtained for all aspects of this study; consent to use their data for analysis and publication was obtained from all subjects and all studyrelated procedures adhered to the tenets outlined in the Declaration of Helsinki.
Preoperative and postoperative assessments
Preoperatively, all subjects underwent a comprehensive ophthalmic examination comprising medical, ocular, and family history, slit-lamp examination, dilated funduscopy, and Goldmann applanation tonometry. Moreover, subjective manifest and cylcoplegic refraction was measured using the Jackson cross-cylinder method. Monocular and binocular uncorrected distance visual acuity (UDVA) and CDVA was determined using standard ETDRS charts at 4 meters. In addition, binocular DCNVA was assessed using Jaeger reading charts at a distance of 40 cm. The patients' near addition was determined by continuously adding plus lenses binocularly in 0.25 D steps.
Postoperatively, readings of subjective manifest refraction as well as of monocular and binocular UDVA and CDVA were taken. In addition, uncorrected near visual acuity (UNVA) as well as distance and near spectacle dependence were collected. Furthermore, patients were interviewed about their spectacle dependence for distance and near. The last available postoperative follow-up visit for each patient was used for the present analysis with a resulting mean follow-up period of 7.4 ± 4.5 months.
Monovision assessment
At the preoperative assessment visit, ocular dominance was assessed using the Pointing-a-Finger Test (26) . The programmed target refraction was plano for dominant eyes (distance eyes) and ranged between -0.50 and -1.25 D for nondominant eyes (near eyes). Target refraction in the nondominant eye was determined by means of a monovision trial in the clinic using trial lenses in a trial frame. In regular contact lens wearers, a contact lens monovision trial at home was conducted instead. For patients with a binocular near addition (determined as described previously) of 1.25 D or higher, the monovision trial was conducted with addition of a +1.25 D lens to the manifest refraction of the nondominant eye. In case of monovision intolerance (e.g. cross-blur, dizziness, discomfort), the near addition was gradually reduced in 0.25 D steps until a tolerable level was reached. For patients with a binocular near addition of 1.00 D or less, the identical monovision trial was conducted starting with a plus lens equivalent to the subjects' binocular near addition.
Small incision lenticule extraction surgery
All SMILE procedures were performed by one of two highly experienced corneal surgeons (M.D., S.G.P.) using the VisuMax 500-kHz femtosecond laser system (Carl Zeiss Meditec AG). The technical principles of the SMILE procedure have been outlined in detail elsewhere (27) . In all cases, an optical zone of 6.5 mm was created. The intended cap diameter was 7.8-7.9 mm and the intended cap thickness ranged between 120 and 140 µm. For manual extraction of the refractive lenticule, a 4.00-mm incision was created by the femtosecond laser centered at the 45° position in left eyes and at 135° in right eyes.
The postoperative treatment regimen consisted of dexamethasone 0.1% and tobramycin 0.3% eyedrops 6 times daily for 1 week. Thereafter, rimexolone 1% eyedrops were tapered over the course of 1 month starting with a 4 times daily application. In addition, patients were encouraged to use preservative-free lubricating eyedrops as individually required.
Statistical analysis
Statistical analysis was performed using SPSS 23.0.2. for Macintosh (IBM). First, histogram frequency analysis was conducted in conjunction with the Shapiro-Wilk test to evaluate the normality of data. For preoperative versus postoperative comparisons of non-normally distributed data, the Wilcoxon signed-rank test was used (e.g., for the comparison of preoperative CDVA with postoperative UDVA). Independent samples t test was applied for group comparisons of normally distributed data (e.g., for the comparison of corneal K-readings between distance and near eyes). To assess the association between target refraction and patient age, the Spearman rank correlation analysis was applied. A p value of <0.05 was defined as indicative of statistical significance.
Results
Review of our institution's electronic patient database resulted in a total of 49 presbyopic subjects who met all inclusion criteria. The identified patients underwent SMILE monovision between July 17, 2013, and December 12, 2016, in the SMILE Eye Clinic Linz, Austria. Participants' mean age was 49.1 ± 3.0 years and female to male ratio was 30:19. A summary of patients' baseline characteristics and SMILE treatment parameters are presented in Table I . Mean preoperative binocular near addition was +1.15 ± 0.43 D. There were no statistically significant differences in the investigated baseline and treatment parameters between distance and near eyes. The right eye was the dominant (distance) eye in 37 (75.5%) of 49 subjects. With regards to intraoperative complications, suction loss was encountered in 1 (1.0%) eye. As the suction loss occurred during the anterior lenticule cut, suction could be reapplied and the procedure was successfully completed. No postoperative complications were encountered and no enhancements or retreatments were performed.
Refractive accuracy
Mean target SE refraction was -0.01 ± 0.14 D for distance eyes and -0.82 ± 0.24 D for near eyes, corresponding to a mean planned anisometropia of 0.81 ± 0.29 D. Target refraction in near eyes was statistically significantly correlated with age ( Fig. 1) . Mean achieved SE was -0.27 ± 0.40 D in distance eyes and -0.93 ± 0.38 D in near eyes, resulting in a mean induced anisometropia of 0.66 ± 0.50 D. Refractive accuracy in distance and near eyes is analyzed in Figure 2 . Mean deviation from target SE refraction was borderline statistically significantly greater in distance eyes (-0.25 ± 0.39 D) than in near eyes (-0.11 ± 0.33 D) (p = 0.049). 
Distance visual acuity

Near visual acuity
Monovision efficacy
The combined cumulative histogram for postoperative binocular UDVA and UNVA is presented in Figure 5 . A total of 
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35 (71%) patients achieved both a binocular UDVA of ≥20/20 and a binocular UNVA of J1 (20/25) or better; 41 (84%) patients had ≥20/20 of UDVA and were able to read J2 (20/32) or better. All (100%) patients achieved ≥20/25 of UDVA and J3 (20/40) or better UNVA.
Spectacle independence
Complete spectacle independence for distance and near vision was achieved by 41 (84%) of 49 patients. Independence from reading glasses was achieved by 45 patients (92%). Four patients (8%) stated that they required reading glasses for small print. In 3 of these cases, a positive deviation from target SE refraction (overcorrection) of the near eye was encountered with a mean deviation from target SE refraction of +0.50 ± 0.25 D. Distance spectacle independence was achieved in 45 (92%) cases; 4 (8.2%) patients stated that they used distance glasses exclusively for night driving. In 3 of these, a surgical refractive undercorrection of the distance eye was seen, with deviations from target refraction ranging between -0.75 and -1.13 D. Monocular UDVA in the distance eye was 20/25 and binocular UDVA was 20/20 in all 3 cases. In the fourth case, achieved manifest SE refraction in the distance eye was almost plano (-0.13 D) and monocular UDVA was 20/12. Nevertheless, this 52-year-old woman complained of disturbing cross-blur during night driving that necessitated spectacle correction of the near eye for driving at nighttime. 
Safety
Discussion
The present study demonstrated the safety and efficacy of SMILE monovision to simultaneously correct myopia or myopic astigmatism and presbyopia. We are unaware of previous reports of SMILE monovision and could not find reference to it in a PubMed database search. By inducing a mean SE refraction of -0.93 D in nondominant eyes, highly satisfactory binocular distance and near visual acuity levels could be achieved. More than 84% of patients showed ≥20/20 of UDVA and at the same time were able to read J2 (20/32 Snellen equivalent) or better. Our data endorse the safety of the procedure as the achieved binocular UDVA levels were on par with preoperative CDVA; loss of Snellen lines was negligible, with 3 patients (6%) losing 1 line of binocular CDVA; and no patient elected to undergo refractive enhancement.
The primary goal of laser monovision is to enable spectacle-free reading at a normal reading distance and at the same time maintain acceptable binocular uncorrected distance visual function. Hence, one major concern when pursuing monovision is the potential of compromising distance visual acuity. In our study, however, mean postoperative binocular UDVA was satisfactory (-0.05 logMAR or 20/18 Snellen equivalent) and was virtually identical with preoperative binocular CDVA. Even though postoperative binocular UDVA was statistically significantly inferior as compared to the full spectacle correction (-0.08 logMAR, 20/17 Snellen equivalent), the clinical significance of this small absolute difference may be questioned. Despite the high level of achieved UDVA, we noted an 8% rate of distance spectacle dependence. It needs to be considered, however, that all 4 affected patients required distance glasses exclusively for night driving and none of them requested refractive enhancement for improvement of their binocular distance vision. Besides a mild surgical refractive undercorrection of the distance eye in 3 of these 4 cases, reduced intraocular blur suppression under mesopic and scotopic conditions-a well-known phenomenon that deteriorates night vision quality in monovision patients (5, 28)-might have contributed to the patients' nocturnal spectacle dependence.
While maintaining acceptable distance visual function, SMILE monovision was also able to provide a highly satisfactory mean unaided near visual acuity level of J1 (20/25 Snellen equivalent) that distinctly exceeded the mean preoperative DCNVA of J3 (20/40 Snellen equivalent). Postoperatively, the proportion of patients who could read J1 or better without near addition more than quadrupled to 82% as compared with preoperative distance-corrected near vision. Nevertheless, the achieved UNVA was not on par with the mean preoperative corrected near visual function of J1+ (20/20 Snellen equivalent). This was an anticipated outcome since our relatively conservative monovision protocol limited the amount of surgically induced anisometropia to a maximum of 1.25 D irrespective of the patients' preoperative binocular near addition. On average, the latter amounted to +1.15 D while the mean aimed SE refraction in near eyes was only -0.82 D. Despite this mini-monovision approach, a respectable proportion of 92% of patients achieved reading spectacle independence. Even though the amount of spherical aberration induced by SMILE may be negligible (22) (23) (24) (25) , SMILE seems to induce other higher-order aberrations such as coma (22, 24, 29, 30) , which may have contributed to this excellent unaided near visual function by enhancing the patients' depth of field (17) . In the end, it needs to be considered that our sample of presbyopic patients was of relatively young age (mean 49 years) and further research is warranted 
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to evaluate the efficacy of this SMILE monovision protocol in more advanced presbyopia.
Besides unaided distance and near visual function, refractive enhancement rate may be regarded as a further indicator of laser monovision success. It is well-known that distance eyes of laser monovision patients show a propensity to require refractive enhancement. For example, Braun et al (4) reported a 27.9% enhancement rate in distance eyes of 172 patients who underwent LASIK monovision, which the authors attributed to their reduced tolerance for residual refractive error as compared with near eyes or patients undergoing bilateral full distance correction (4). In our study of SMILE monovision, we observed a mild overall refractive undercorrection of -0.25 D in distance eyes and 3 patients depended on spectacles for night driving due to undercorrection of their distance eyes. Of note, none of these 3 patients opted for secondary refractive enhancement. It needs to be considered, however, that our preferred enhancement technique after SMILE is surface ablation with mitomycin C (31) and the prospect of a painful retreatment procedure with potentially prolonged visual recovery may have discouraged these patients from undergoing enhancement of their distance eye. The authors acknowledge the fact that retreatment after SMILE remains a highly debatable topic that poses a disadvantage as compared to femtosecond LASIK.
There are several limitations to this study. Even though all preoperative and postoperative examinations were conducted following our institution's standard protocols (e.g., for manifest refraction and visual acuity readings), this study was primarily limited by its retrospective nature. Moreover, no control group (e.g., LASIK monovision) was incorporated. In addition, contrast sensitivity function and stereoacuity were not assessed. Finally, no standardized reading chart was used for determining near visual acuity (e.g., such as the European Society of Cataract and Refractive Surgeons charts (32)).
In conclusion, in spite of the fact that SMILE does not permit controlled induction of spherical aberration and, hence, modulation of depth of field (as is possible with excimerbased procedures), the present study demonstrated favorable clinical outcomes of SMILE monovision. The observed postoperative levels of uncorrected distance and near visual acuity were highly satisfactory and more than 90% of patients achieved complete spectacle independence for near vision. In our hands, high monovision tolerance could be realized by pursuing a conservative monovision protocol in conjunction with preoperative monovision simulation. Our data encourage future work to assess the efficacy of different SMILE monovision protocols in further populations (e.g., in patients with more advanced presbyopia).
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